Probiodrug AG | Ownership
Companies that own Probiodrug AG
Bellevue Asset Management AG
1,077,378
13.16%
-860
0.06%
07/31/2018
Aviva Investors Global Services Ltd.
741,624
9.06%
0
0.01%
12/31/2016
JPMorgan Asset Management (UK) Ltd.
235,334
2.88%
-167,930
0%
01/11/2018
AXA Investment Managers UK Ltd.
146,773
1.79%
0
0%
02/28/2018
APG Asset Management NV
47,393
0.57%
-24,523
0%
03/31/2018
Edmond de Rothschild Asset Management (Luxembourg) SA
35,000
0.43%
0
0.02%
06/30/2017
Lupus alpha Asset Management AG
30,000
0.37%
30,000
0.01%
12/31/2017
Schroder Investment Management Ltd.
27,750
0.34%
0
0%
05/31/2018
Banca Credinvest SA (Investment Management)
12,600
0.15%
0
0.03%
07/26/2018
AcomeA SGR SpA
2,494
0.03%
194
0%
10/31/2017
| Address |
Weinbergweg 22
Halle Sachsen-Anhalt 06120
Germany
|
|
Employees
|
- |
| Website |
http://www.probiodrug.de |
| Updated |
07/08/2019 |
| Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany. |
